FAQ · GLP-1 · Editorial commentary
Where does the authoritative information on Mounjaro side effects live?
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated 2026-06-01
Editorial commentary on the Patient Information Leaflet and SmPC for Mounjaro (tirzepatide). The full list of side effects, with the MHRA-approved frequency categories and the guidance on what to do, is in the PIL supplied in the medication box and in the SmPC published on emc.medicines.org.uk. PeptideClear does not reproduce the side-effect detail or publish a triage runbook, because the right action for any specific symptom depends on individual circumstances a general website cannot know. For severe or persistent symptoms contact your prescriber or NHS 111; in an emergency call 999. Suspected side effects can be reported through the MHRA Yellow Card scheme.
If you are unwell right now, this page is not the right resource. Read the Patient Information Leaflet supplied with your medication and contact your prescriber. If you cannot reach your prescriber and are unsure, call NHS 111. In an emergency call 999. Suspected side effects can be reported through the MHRA Yellow Card scheme.
Why we do not reproduce the side-effect detail here
Mounjaro is a UK prescription-only medicine. The full list of reported side effects, the frequency categories (very common, common, uncommon, rare), the guidance on what to do for each, and the warnings about serious effects are all set out in the MHRA-approved Patient Information Leaflet supplied in the medication box and in the SmPC published on emc.medicines.org.uk. Those documents are the authoritative source, kept current by the marketing-authorisation holder under MHRA oversight. A general consumer website is not the right place to reproduce that detail, because the right action for any specific symptom also depends on factors a third-party website cannot know: your individual clinical picture, where you are in titration, what other medicines you take, and what your prescriber has told you to do.
Where to check
- · The Patient Information Leaflet supplied with your medication, or the current version on emc.medicines.org.uk.
- · The SmPC for tirzepatide on the MHRA Products database.
- · Your prescriber: NHS GP, NHS specialist weight-management service, private clinic prescriber, or pharmacist prescriber.
- · Your dispensing pharmacist.
- · NHS 111 for urgent advice when you cannot reach your prescriber; 999 in an emergency.
- · MHRA Yellow Card to report a suspected side effect.
Decision routing: the SmPC sets the titration; the PIL lists side effects; your UK-licensed prescriber decides individual dosing; NHS 111 and 999 are the safety net; report concerns through the MHRA Yellow Card scheme. This page is editorial commentary, not clinical advice.
Related: Mounjaro reference · why the PIL is authoritative · MHRA Yellow Card explained · Ozempic and Mounjaro brand confusion.